| Literature DB >> 35690655 |
Katharina Grimm1, Daniel Niederer2, Albert Nienhaus3, David A Groneberg4, Tobias Engeroff5.
Abstract
Mask induced airway resistance and carbon dioxide rebreathing is discussed to impact gas exchange and to induce discomfort and impairments in cognitive performance. N = 23 healthy humans (13 females, 10 males; 23.5 ± 2.1 years) participated in this randomized crossover trial (3 arms, 48-h washout periods). During interventions participants wore either a surgical face mask (SM), a filtering face piece (FFP2) or no mask (NM). Interventions included a 20-min siting period and 20 min steady state cycling on an ergometer at 77% of the maximal heart rate (HR). Hemodynamic data (HR, blood pressure), metabolic outcomes (pulse derived oxygen saturation, capillary carbon dioxide (pCO2), and oxygen partial pressure (pO2), lactate, pH, base excess), subjective response (ability to concentrate, arousal, perceived exertion) and cognitive performance (Stroop Test) were assessed. Compared to NM, both masks increased pCO2 (NM 31.9 ± 3.3 mmHg, SM = 35.2 ± 4.0 mmHg, FFP2 = 34.5 ± 3.8 mmHg, F = 12.670, p < 0.001) and decreased pH (NM = 7.42 ± 0.03, SM = 7.39 ± 0.03, FFP2 = 7.39 ± 0.04, F = 11.4, p < 0.001) during exercise. The FFP2 increased blood pressure during exercise (NM = 158 ± 15 mmHg, SM = 159 ± 16 mmHg, FFP2 = 162 ± 17 mmHg, F = 3.21, p = 0.050), the SM increased HR during sitting (NM = 70 ± 8 bpm, SM = 74 ± 8 bpm, FFP2 = 73 ± 8 bpm, F = 4.70, p = 0.014). No mask showed any comparative effect on other hemodynamic, metabolic, subjective, or cognitive outcomes. Mask wearing leads to slightly increased cardiovascular stress and elevated carbon dioxide levels during exercise but did not affect cognitive performance or wellbeing.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35690655 PMCID: PMC9188275 DOI: 10.1038/s41598-022-13711-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1CONSORT flow diagram of the protocol procedures. Twenty-three participants were assigned to either the surgical face mask, the FFP2 mask or the unmasked condition by randomisation, followed by crossover to the other conditions. NM no mask, SM surgical mask, FFP2 Filtering Face Piece Type 2, CONSORT 2010 Consolidated Standards of Reporting.
Baseline demographics and clinical characteristics.
| Outcome/dimension | Unit | Participants | T-test | ||
|---|---|---|---|---|---|
| Total | Males | Females | T-value, P-value | ||
| Mean ± SD | |||||
| Age | years | 23.5 ± 2.1 | 23.8 ± 2.7 | 23.2 ± 1.6 | 0.627, 0.538 |
| Weight | kg | 69.8 ± 16.6 | 81.7 ± 17.2 | 60.7 ± 8.8 | 3.827, < 0.001* |
| Height | cm | 172 ± 10 | 181 ± 6 | 165 ± 5 | 7.381, < 0.001* |
| Body mass index | kg/m2 | 23.3 ± 3.5 | 24.8 ± 4.3 | 22.2 ± 2.4 | 1.854, 0.078 |
| Vigorous physical activity | min/week | 75.4 ± 59.9 | 105.0 ± 65.2 | 52.7 ± 45.8 | 2.264, 0.034* |
| Moderate physical activity | min/week | 73.0 ± 64.7 | 61.0 ± 64.1 | 82.3 ± 66.2 | − 0.776, 0.447 |
| Walking | min/week | 124.6 ± 88.0 | 133.0 ± 82.8 | 118.1 ± 94.7 | 0.395, 0.697 |
| Sedentary behaviour | min/day | 391.3 ± 184.4 | 372.0 ± 132.1 | 406.2 ± 220.7 | − 0.432, 0.670 |
| Total physical activity | MET-min/week | 1306.7 ± 674.0 | 1522.9 ± 692.9 | 1140.4 ± 635.4 | 1.376, 0.183 |
| HR | bpm | 79 ± 9 | 74 ± 9 | 83 ± 7 | − 2.414, 0.025* |
| SBP | mmHg | 123 ± 11 | 132 ± 9 | 117 ± 9 | 3.949, < 0.001* |
| DBP | mmHg | 81 ± 8 | 87 ± 7 | 76 ± 5 | 4.387, < 0.001* |
| Pulse derived blood oxygen saturation | % | 96.8 ± 1.0 | 96.2 ± 0.8 | 97.2 ± 0.9 | − 2.816, 0.010* |
| pH | 7.45 ± 0.02 | 7.44 ± 0.01 | 7.45 ± 0.02 | − 2.639, 0.015* | |
| pCO2 | mmHg | 34.53 ± 2.91 | 36.80 ± 2.29 | 32.78 ± 1.99 | 4.503, < 0.001* |
| pO2 | mmHg | 85.05 ± 16.18 | 84.51 ± 7.09 | 85.47 ± 21.02 | − 0.138, 0.892 |
| Lactate | mmol/l | 1.30 ± 0.53 | 1.38 ± 0.60 | 1.24 ± 0.49 | 0.606, 0.551 |
| Base excess | mmol/l | 0.24 ± 1.32 | 0.99 ± 0.90 | − 0.33 ± 1.33 | 2.690, 0.014* |
| School and study years | years | 16.5 ± 0.9 | 16.4 ± 0.6 | 16.6 ± 1.1 | − 0.576, 0.571 |
| Stroop OFF-Time | sec | 53.6 ± 6.3 | 52.6 ± 7.8 | 54.5 ± 5.1 | − 0.715, 0.483 |
| Stroop ON-Time | sec | 57.4 ± 7.8 | 55.4 ± 9.7 | 58.9 ± 5.8 | − 1.049, 0.306 |
Significant differences between sexes are indicated with an asterisk (*).
HR heart rate, SBP systolic blood pressure, DBP diastolic blood pressure, pCO partial pressure of carbon dioxide, pO partial pressure of oxygen, MET metabolic equivalent of task, min minute, bpm beats per minute, sec seconds.
*Independent Samples T-Test.
Results of hemodynamic, metabolic, subjective and performance outcomes during the sitting and bicycle ergometer intervention with no mask (NM), surgical mask (SM) or filtering face piece (FFP2) application.
| Outcome | Unit | Manipulation | ANOVA time effect, F value, p value, effect size eta squared (η2) | Post-hoc comparisons p-values | ||||
|---|---|---|---|---|---|---|---|---|
| No mask (NM) | Surgical mask (SM) | FFP2 | ||||||
| NM vs. SM | NM vs. FFP2 | SM vs. FFP2 | ||||||
| Hemodynamic parameters | ||||||||
| HR | bpm | 70 ± 8 | 74 ± 8 | 73 ± 8 | 4.70, 0.014*, 0.047 | 0.009 | 0.236 | 0.951 |
| SBP | mmHg | 119 ± 9 | 119 ± 10 | 119 ± 9 | 0.120, 0.887 | |||
| DBP | mmHg | 79 ± 7 | 78 ± 7 | 79 ± 8 | 1.21, 0.309 | |||
| Metabolic parameters | ||||||||
| SpO2 | % | 97.2 ± 1.0 | 96.8 ± 0.9 | 97.0 ± 1.0 | 2.07, 0.193 | |||
| pH | 7.44 ± 0.02 | 7.44 ± 0.03 | 7.44 ± 0.02 | 0.168, 0.846 | ||||
| pCO2 | mmHg | 34.6 ± 3.16 | 35.3 ± 2.99 | 35.5 ± 3.42 | 1.86, 0.168 | |||
| PO2 | mmHg | 84.4 ± 7.01 | 84.0 ± 5.38 | 84.2 ± 6.21 | 0.0227, 0.978 | |||
| Lactate | mmol/l | 1.24 ± 0.54 | 1.11 ± 0.43 | 1.11 ± 0.36 | 1.48, 0.238 | |||
| BE | mmol/l | − 0.04 ± 1.22 | 0.35 ± 1.42 | 0.21 ± 1.14 | 0.845, 0.437 | |||
| Subjective parameters | ||||||||
| Feeling scale | 3.2 ± 1.5 | 2.8 ± 1.7 | 3.3 ± 1.7 | 0.906, 0.310 | ||||
| Arousal | 2.8 ± 1.3 | 2.6 ± 1.1 | 2.8 ± 1.1 | 0.304, 0.739 | ||||
| Ability to concentrate | 5.4 ± 1.9 | 5.6 ± 1.5 | 5.6 ± 1.6 | 0.459, 0.635 | ||||
| Performance parameters | ||||||||
| Watt | W | 118 ± 35 | 119 ± 35 | 118 ± 33 | 0.349, 0.707 | |||
| Relative Watt | W/kg | 1.7 ± 0.4 | 1.7 ± 0.4 | 1.7 ± 0.3 | 0.432, 0.652 | |||
| Hemodynamic parameters | ||||||||
| HR | bpm | 141 ± 5 | 143 ± 7 | 141 ± 6 | 0.725, 0.490 | |||
| SBP | mmHg | 158 ± 15 | 159 ± 16 | 162 ± 17 | 3.21, 0.050*, 0.014 | 1.000 | 0.044 | 0.329 |
| DBP | mmHg | 75 ± 8 | 74 ± 6 | 75 ± 8 | 0.185, 0.832 | |||
| Metabolic parameters | ||||||||
| SpO2 | % | 95.6 ± 1.0 | 95.4 ± 1.2 | 95.4 ± 1.1 | 0.312, 0.734 | |||
| pH | 7.42 ± 0.03 | 7.39 ± 0.03 | 7.39 ± 0.04 | 11.4, < .001*, 0.136 | < 0.001 | 0.002 | 0.874 | |
| pCO2 | mmHg | 31.9 ± 3.33 | 35.2 ± 4.00 | 34.5 ± 3.80 | 13.1, < .001*, 0.134 | < 0.001 | 0.006 | 0.879 |
| PO2 | mmHg | 80.9 ± 7.13 | 80.5 ± 14.1 | 81.8 ± 17.9 | 0.0575, 0.944 | |||
| Lactate | mmol/l | 5.49 ± 2.56 | 5.15 ± 2.35 | 5.48 ± 2.14 | 0.995, 0.378 | |||
| BE | mmol/l | − 3.03 ± 1.80 | − 2.78 ± 2.04 | − 3.33 ± 1.95 | 1.72, 0.190 | |||
| Subjective parameters | ||||||||
| Feeling scale | 2.4 ± 1.7 | 1.8 ± 1.6 | 2.3 ± 1.6 | 2.04, 0.144 | ||||
| Perceived exertion | Borg scale | 14.1 ± 0.8 | 14.3 ± 0.9 | 14.5 ± 0.9 | 2.00, 0.147 | |||
| Arousal | 4.5 ± 1.0 | 4.4 ± 0.8 | 4.5 ± 0.9 | 0.295, 0.746 | ||||
| Ability to concentrate | 6.0 ± 1.6 | 5.9 ± 2.0 | 6.1 ± 1.6 | 0.166, 0.848 | ||||
Significant effects of mask condition are indicated with asterisks (*).
HR heart rate, SBP systolic blood pressure, DBP diastolic blood pressure, SpO pulse derived oxygen saturation, pCO partial pressure of carbon dioxide, pO partial pressure of oxygen, BE base excess, bpm beats per minute.
Figure 2Mean values and 95% confidence intervals of heart rate data of all assessed time points during the sitting and the exercise condition with no mask, a surgical mask and a filtering face piece type 2 (FFP2).
Figure 3Mean values and 95% confidence intervals for systolic blood pressure, capillary blood carbon dioxide partial pressure and pH during exercise with no mask, a surgical mask or a filtering face piece type 2 (FFP2) and pre- to post exercise changes in cognitive attention (Stroop OFF-Time) and executive function (Stroop ON-Time) performance in seconds. Asterisks symbols (*) indicate significant time effects; Hash symbols (#) indicate significant pre to post exercise change in cognitive performance.
Pre intervention and pre to post intervention differences of cognitive attention (Stroop OFF-Time) and executive function (Stroop ON-Time) performance for the sitting and exercise intervention with no mask, surgical mask or filtering face piece type 2 (FFP2).
| Outcome | Pre intervention values | Pre to post differences (post intervention values) | ANOVA | ||||
|---|---|---|---|---|---|---|---|
| No mask | Surgical mask | FFP2 | No mask | Surgical mask | FFP2 | F-value, p-value | |
| OFF-Time | 50.3 ± 7.3 | 49.4 ± 7.4 | 50.1 ± 6.7 | − 1.2 ± 3.4 (49.0 ± 7.1) | − 0.3 ± 3.2 (49.1 ± 7.0) | 0.5 ± 4.1 (50.6 ± 8.0) | 1.24, 0.298 (1.38, 0.262) |
| ON-Time | 53.1 ± 7.2 | 52.9 ± 7.7 | 54.4 ± 8.4 | − 1.0 ± 3.0 (52.1 ± 7.4) | 0.4 ± 5.0 (53.3 ± 8.0) | − 1.2 ± 4.1 (53.2 ± 8.2) | 1.03, 0.366 (0.624, 0.540) |
| OFF-Time | 50.3 ± 7.3 | 49.4 ± 7.4 | 50.1 ± 6.7 | − 4.0 ± 4.0 (46.3 ± 6.2) | − 3.0 ± 3.9 (46.5 ± 6.8) | − 2.2 ± 3.8 (47.9 ± 7.0) | 1.11, 0.337 (2.14, 0.130) |
| ON-Time | 53.1 ± 7.2 | 52.9 ± 7.7 | 54.4 ± 8.4 | − 3.3 ± 2.6 (49.8 ± 7.0) | − 2.3 ± 4.8 (50.6 ± 8.3) | − 2.8 ± 3.2 (51.6 ± 7.8) | 0.408, 0.668 (1.61, 0.212) |
Values are displayed as mean ± standard deviation.